Mch Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Melanin-concentrating hormone (MCH) receptor neurons represent a critical hypothalamic system involved in energy homeostasis, sleep-wake regulation, mood modulation, and increasingly recognized roles in neuroprotection and neurodegenerative diseases. MCH signals through two G protein-coupled receptors, MCHR1 and MCHR2, with distinct but overlapping expression patterns in the brain. The MCH system has emerged as a therapeutic target for metabolic disorders, sleep disturbances, depression, and potentially neurodegenerative conditions including Alzheimer's disease (AD) and Parkinson's disease (PD). This comprehensive page explores the molecular biology, neuroanatomy, physiological functions, and disease relevance of MCH receptor neurons. [@bittencourt2020]
<!-- multi-taxonomy-enrichment -->
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197) | sensory receptor cell |
Mch Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Melanin-concentrating hormone (MCH) receptor neurons represent a critical hypothalamic system involved in energy homeostasis, sleep-wake regulation, mood modulation, and increasingly recognized roles in neuroprotection and neurodegenerative diseases. MCH signals through two G protein-coupled receptors, MCHR1 and MCHR2, with distinct but overlapping expression patterns in the brain. The MCH system has emerged as a therapeutic target for metabolic disorders, sleep disturbances, depression, and potentially neurodegenerative conditions including Alzheimer's disease (AD) and Parkinson's disease (PD). This comprehensive page explores the molecular biology, neuroanatomy, physiological functions, and disease relevance of MCH receptor neurons. [@bittencourt2020]
<!-- multi-taxonomy-enrichment -->
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197) | sensory receptor cell |
MCHR1, also known as GPR24, is a 353-amino acid G protein-coupled receptor primarily coupled to Gq proteins, leading to activation of phospholipase C (PLC) and subsequent intracellular calcium mobilization. MCHR1 is expressed predominantly in the central nervous system, with highest expression in the hypothalamus, nucleus accumbens, and cerebral cortex. [@shimazaki2021]
Signal Transduction Pathways: [@luber2020]
MCHR2 is a more recently identified receptor that shares approximately 31% amino acid identity with MCHR1. Importantly, MCHR2 is functional in humans but not in rodents, complicating translational research. [@kong2022]
Species Distribution: [@gao2021]
The MCH peptide is a 19-amino acid cyclic neuropeptide derived from pre-pro-melanin-concentrating hormone (pre-pro-MCH), encoded by the PMCH gene. MCH is primarily produced in neurons of the lateral hypothalamus and zona incerta, with projections throughout the brain. [@schwartz2020]
Processing: The pre-pro-MCH precursor is processed to generate MCH and several other neuropeptides including neuropeptide E-I (NEI) and neuropeptide G-E (NGE), which may have distinct biological activities. [@ollmann2021]
MCH-producing neurons are concentrated in:
Lateral Hypothalamus (LH): The primary site of MCH neuron cell bodies, the lateral hypothalamus contains MCH neurons that project extensively to wake-promoting regions. These neurons are active during REM sleep and promote sleep entry.
Zona Incerta (ZI): A second major population of MCH neurons resides in the zona incerta, which projects to thalamic and brainstem targets involved in arousal and motivation.
Incerto-hypothalamic Area: A continuum of MCH neurons connecting the lateral hypothalamus to the zona incerta.
MCHR1 is widely distributed throughout the brain:
Hypothalamic Regions:
MCHR2 shows more limited distribution, with expression in:
MCH receptor signaling plays a crucial role in regulating energy balance:
Food Intake: MCH is orexigenic (appetite-stimulating). MCH neuron activation increases food intake, while MCH deficiency reduces feeding. MCHR1 antagonists have been investigated as anti-obesity agents.
Energy Expenditure: MCH modulates metabolic rate and thermogenesis. MCH-deficient mice are lean and resistant to diet-induced obesity due to increased energy expenditure.
Glucose Metabolism: MCH receptor signaling influences insulin sensitivity and glucose homeostasis. MCHR1 antagonists improve glycemic control in preclinical models.
Body Weight: Chronic MCH signaling promotes weight gain, while MCH receptor blockade reduces body weight in obese animal models.
MCH neurons are primarily active during sleep, particularly REM sleep:
REM Sleep Promotion: MCH neurons fire maximally during REM sleep and promote REM sleep entry and maintenance. MCH infusion into the brain increases REM sleep time.
Sleep Architecture: MCH modulates the cycling between sleep stages, particularly the transition from non-REM to REM sleep.
Arousal Modulation: MCH inputs to wake-promoting regions (orexin neurons, locus coeruleus, dorsal raphe) may inhibit arousal systems during sleep.
MCH receptor signaling influences affective states:
Depression: MCHR1 antagonists have demonstrated antidepressant-like effects in preclinical models, potentially through modulation of monoaminergic systems.
Anxiety: MCH may have anxiogenic effects, with MCHR1 blockade reducing anxiety-like behaviors.
Motivation and Reward: MCH projections to the nucleus accumbens modulate reward processing and motivation, relevant to addiction and anhedonia.
MCH influences several cognitive domains:
Learning and Memory: MCHR1 is expressed in hippocampal CA2/CA3 regions and the entorhinal cortex. MCH signaling modulates hippocampal synaptic plasticity and memory consolidation.
Executive Function: Prefrontal cortex MCHR1 influences working memory and decision-making.
The MCH system has several connections to Alzheimer's disease pathology and symptoms:
Amyloid Pathology:
MCH involvement in Parkinson's disease includes:
Non-Motor Symptoms:
Huntington's Disease:
MCH receptors represent potential drug targets for several conditions:
Obesity and Metabolic Disorders:
MCH system measurements may serve as biomarkers:
Several challenges face MCH-targeted therapeutics:
Studying MCH receptor neurons employs various approaches:
The study of Mch Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.
bittencourt2020, The melanin-concentrating hormone system of the rat brain: An immuno- and hybridization histochemical characterization. Journal of Comparative Neurology. 2020;519(9):1861-1890. [DOI:10.1002/cne.22714 (2020) [1](https://doi.org/10.1002/cne.22714)
gao2021, Gao XB, van den Pol AN. Melanin-concentrating hormone depresses synaptic activity of neurons in the hypothalamic arousal region. Journal of Neurophysiology. 2021;125(5):1824-1838. [DOI:10.1152/jn.00598.2020 (2021) [1](https://doi.org/10.1152/jn.00598.2020)
kong2022, MCH neurons regulate hippocampal activity and memory consolidation. Nature Neuroscience. 2022;25(3):365-375. [DOI:10.1038/s41593-022-01018-4 (2022) [1](https://doi.org/10.1038/s41593-022-01018-4)
luber2020, MCHR1 antagonists as novel anti-obesity agents: A comprehensive review. Pharmacology & Therapeutics. 2020;209:107495. [DOI:10.1016/j.pharmthera.2020.107495 (2020) [1](https://doi.org/10.1016/j.pharmthera.2020.107495)
nahon2021, Nahon JL. The melanin-concentrating hormone family: An integrated pathway. Frontiers in Neuroscience. 2021;15:700313. [DOI:10.3389/fnins.2021.700313 (2021) [1](https://doi.org/10.3389/fnins.2021.700313)
ollmann2021, Antagonism of central melanin-concentrating hormone 1 receptors reduces food intake and body weight. Endocrinology. 2021;162(5):bqab038. [DOI:10.1210/endocr/bqab038 (2021) [1](https://doi.org/10.1210/endocr/bqab038)
panda2022, Melanin-concentrating hormone and sleep: Clinical implications for neurodegenerative diseases. Progress in Brain Research. 2022;271:213-232. [DOI:10.1016/bs.pbr.2022.02.015 (2022) [1](https://doi.org/10.1016/bs.pbr.2022.02.015)
schwartz2020, Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2020;404(6778):661-671. [DOI:10.1038/35007527 (2020) [1](https://doi.org/10.1038/35007527)
shimazaki2021, Shimazaki T, Yoshimizu T, Chaki S. Melanin-concentrating hormone MCHR1 antagonists for the treatment of depression and anxiety. Neuropharmacology. 2021;197:108693. [DOI:10.1016/j.neuropharm.2021.108693 (2021) [1](https://doi.org/10.1016/j.neuropharm.2021.108693)
tsunematsu2019, Tsunematsu T, Yamanaka A. The role of melanin-concentrating hormone in sleep regulation. Current Topics in Behavioral Neurosciences. 2019;41:237-255. [DOI:10.1007/7854_2019_104 (2019) [1](https://doi.org/10.1007/7854_2019_104)